{"filing":{"accession_number":"0001096906-26-001112","cik":"0000706698","ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","form":"8-K","filing_date":"2026-07-23","report_date":null,"primary_document":"utmd-20260723_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690626001112/utmd-20260723_8k.htm"},"events":[{"id":19972,"run_id":17981,"accession_number":"0001096906-26-001112","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Utah Medical Products disclosed financial results for the second calendar quarter and first half of 2026, including detailed revenue, gross profit, operating income, and margin analysis compared to prior-year periods.","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":[{"id":19209,"accession_number":"0001096906-26-001112","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release dated July 23, 2026, disclosing Utah Medical Products' financial results for the second calendar quarter and first half of 2026, including detailed revenue, gross profit, operating income, and margin analysis. The filing explicitly states it is furnished pursuant to Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases on Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T19:14:40.773589+00:00","company_name":"","ticker":null,"filing_date":""},{"id":19210,"accession_number":"0001096906-26-001112","item_number":"99.1","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release dated July 23, 2026 disclosing Utah Medical Products' financial results for the second calendar quarter and first half of 2026, including detailed revenue, gross profit, operating income, and margin analysis. The filing explicitly states \"UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026\" and provides comprehensive financial metrics comparing 2Q and 1H 2026 to prior-year periods, which is the hallmark of an earnings release disclosure typically filed under Item 2.02 or Item 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T19:14:40.773589+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19209,"accession_number":"0001096906-26-001112","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release dated July 23, 2026, disclosing Utah Medical Products' financial results for the second calendar quarter and first half of 2026, including detailed revenue, gross profit, operating income, and margin analysis. The filing explicitly states it is furnished pursuant to Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases on Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T19:14:40.773589+00:00","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-07-23"},{"id":19210,"accession_number":"0001096906-26-001112","item_number":"99.1","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release dated July 23, 2026 disclosing Utah Medical Products' financial results for the second calendar quarter and first half of 2026, including detailed revenue, gross profit, operating income, and margin analysis. The filing explicitly states \"UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026\" and provides comprehensive financial metrics comparing 2Q and 1H 2026 to prior-year periods, which is the hallmark of an earnings release disclosure typically filed under Item 2.02 or Item 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T19:14:40.773589+00:00","company_name":"UTAH MEDICAL PRODUCTS INC","ticker":"UTMD","filing_date":"2026-07-23"}]}